Antivirals
|
|
Your reliable supplier of generic medications.
|
|
|
Thank-you for your service, everything has arrived without any hiccups
Our billing is certified by:
- What’s best at beating swine flu, soap or gel?
Commuters obsessively scrub their hands with gel.
- Swine flu drug treatment will replace containment strategy
More than 150 people have been diagnosed with swine flu over the past 24 hours as the rate of infection accelerates, pushing the total number of UK cases above 1,000.
- Is the flu jab a waste of time?
On balance, probably not.
- Global flu pandemic would probably kill 62m, study says
Around 62 million people in the world are likely to die if there is a flu pandemic and more than 70,000 of those deaths will be in the UK, according to a statistical analysis published today.
- Vaccine against lethal strain of avian flu ready for human testing
A British drug company is seeking permission to conduct the first human trials of an experimental vaccine against the avian flu virus.
- Patients' Expectations About New HCV Direct-Acting Antivirals Often Unrealistic - Gastroenterology & Endoscopy News
Gastroenterology & Endoscopy NewsPatients' Expectations About New HCV Direct-Acting Antivirals Often UnrealisticGastroenterology & Endoscopy Newsby Christina Frangou San Francisco—Soon after the FDA approved two direct-acting antiviral agents (DAAs) last spring for treating infection with hepatitis C virus (HCV), a 57-year-old black man came to see gastroenterologist Andrew Muir, MD.
- Novartis pays $440m for preclinical hepatitis C drug - PMLiVE
Novartis pays $440m for preclinical hepatitis C drugPMLiVESome 170m people worldwide are affected by the virus and market researchers predict the availability of simpler, oral regimens consisting of directly-acting antivirals used in combination could expand annual HCV drug sales to more than $20bn in the .
- Setback, not disaster, for Gilead hep. C regimen, analysts say - Medical Marketing and Media
Setback, not disaster, for Gilead hep.
- Gilead tops table for antivirals - Pharma Times
Gilead tops table for antiviralsPharma TimesWith combined sales from the top HIV treatment on the market, Atripla, and several other drugs, Gilead Sciences leads the antiviral market, closely followed by Bristol-Myers Squibb, Roche and Merck & Co.
- UK company, OnlineClinic, expands services for STI's, travel medicine - Examiner.com
UK company, OnlineClinic, expands services for STI's, travel medicineExaminer.
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
